ICD for non-ischemic cardiomyopathyNo Abstract available for this article.doi:10.1007/s12181-016-0103-3H. WienekeSpringer NatureDer Kardiologe
non-ischaemic dilated cardiomyopathy (NIDCM)There is current debate regarding the value of implantable cardioverter defibrillators (ICD) in patients with non-ischemic dilated cardiomyopathy (NIDCM). Previous studies (DEFINITE, SCD-HeFT) enrolled patients not treated with optimal medication according to ...
Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006;47:2477 -82.Kadish A, Schaechter A, Subacius H, Thattassery E, Sanders W, Anderson KP, Dyer A, Goldberger J, Levine J. Patients with recently diagnosed non...
ICD electrogramsinferolateral substratenonischemic cardiomyopathyIntroduction The majority of patients with nonischemic cardiomyopathy (NICM) present a perivalvular substrate that is either predominantly antero‐septal (AS) or infero‐lateral (IL), corresponding to specific ventricular tachycardia (VT) ...
ICD in Nonischemic Cardiomyopathy. Introduction: Implantation of an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death (SCD) is controversial in view of the recent DANISH trial which suggested no benefit with ICD for primary prevention in patients with non-...
Inappropriate And Appropriate ICD Therapy In Ischemic And Non-ischemic Cardiomyopathy In The MADIT-RIT TrialJosef Kautzner, MD, PhD
Does Anyone Really Believe the Results of the DANISH Trial?—Implanting an ICD in Nonischemic Cardiomyopathy Patientsdefibrillation‐ICDclinical trialsThe recent publication of the DANISH Trial seems to leave clinicians and patients at a point of therapeutic equipoise regarding the implantation of an ICD...
Improvement In Left Ventricular Function Remains Common After Diagnosis Of Non-ischemic Cardiomyopathy; Implications For Icd ImplantationGian Carlo Giove, MD
The effect of ICD programming on inappropriate and appropriate ICD Therapies in ischemic and nonischemic cardiomyopathy: the MADIT-RIT trial. J Cardiovasc Electrophysiol 2015;26:424-33.Sedlacek K, Ruwald AC, Kutyifa V, McNitt S, Thomsen PE, Klein H, Stockburger M, Wichterle D, Merkely B,...
Introduction: The benefit of implantable cardioverter-defibrillator (ICD) in patients with non-ischemic dilated cardiomyopathy (DCM) is still an issue under discussion. Studies examining the relationship between ventricular scar tissue and ICD shock with cardiac magnetic resonance (CMR) are promising. ...